Sanuwave Health Selected for Inclusion in Russell 2000® Index
Sanuwave Health (NASDAQ: SNWV), a provider of non-invasive wound care solutions, has been selected for inclusion in the Russell 2000® Index as part of the 2025 Russell indexes reconstitution, effective June 30. The company will also be included in the broader Russell 3000® Index and Russell Microcap® Index.
The Russell indexes, which capture the 4,000 largest U.S. stocks by market capitalization, are widely used by investment managers and institutional investors, with approximately $10.6 trillion in assets benchmarked to these indexes as of June 2024. Membership in these indexes remains in place for one year.
Sanuwave Health specializes in regenerative medicine products for wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions through their patented energy transfer technologies.
Sanuwave Health (NASDAQ: SNWV), fornitore di soluzioni non invasive per la cura delle ferite, è stata selezionata per l'inclusione nel Russell 2000® Index come parte della ricostituzione degli indici Russell 2025, con effetto dal 30 giugno. L'azienda sarà inoltre inclusa nel più ampio Russell 3000® Index e nel Russell Microcap® Index.
Gli indici Russell, che comprendono le 4.000 maggiori azioni statunitensi per capitalizzazione di mercato, sono ampiamente utilizzati da gestori di investimenti e investitori istituzionali, con circa 10,6 trilioni di dollari in asset benchmarkati su questi indici a giugno 2024. L'appartenenza a questi indici dura un anno.
Sanuwave Health è specializzata in prodotti di medicina rigenerativa per la guarigione delle ferite, ortopedia/spina dorsale, estetica/cosmetica e condizioni cardiache/endovascolari, grazie alle sue tecnologie brevettate di trasferimento di energia.
Sanuwave Health (NASDAQ: SNWV), proveedor de soluciones no invasivas para el cuidado de heridas, ha sido seleccionado para su inclusión en el Russell 2000® Index como parte de la reconstitución de los índices Russell 2025, con vigencia a partir del 30 de junio. La compañía también será incluida en el más amplio Russell 3000® Index y en el Russell Microcap® Index.
Los índices Russell, que abarcan las 4,000 acciones estadounidenses más grandes por capitalización de mercado, son ampliamente utilizados por gestores de inversiones e inversores institucionales, con aproximadamente 10.6 billones de dólares en activos referenciados a estos índices a junio de 2024. La membresía en estos índices se mantiene durante un año.
Sanuwave Health se especializa en productos de medicina regenerativa para la cicatrización de heridas, ortopedia/columna vertebral, estética/cosmética y condiciones cardíacas/endovasculares mediante sus tecnologías patentadas de transferencia de energía.
Sanuwave Health (NASDAQ: SNWV)는 비침습적 상처 치료 솔루션 제공업체로, 2025년 Russell 지수 재구성의 일환으로 Russell 2000® 지수에 포함되기로 선정되었으며, 6월 30일부터 적용됩니다. 또한 이 회사는 더 광범위한 Russell 3000® 지수와 Russell Microcap® 지수에도 포함될 예정입니다.
Russell 지수는 시가총액 기준으로 미국 내 상위 4,000개 주식을 포괄하며, 투자 관리자 및 기관 투자자들 사이에서 널리 사용되고 있습니다. 2024년 6월 기준 약 10.6조 달러의 자산이 이 지수를 벤치마크로 활용하고 있습니다. 이 지수의 구성원 자격은 1년간 유지됩니다.
Sanuwave Health는 특허받은 에너지 전달 기술을 통해 상처 치유, 정형외과/척추, 미용/성형, 심장/내혈관 질환을 위한 재생 의학 제품을 전문으로 합니다.
Sanuwave Health (NASDAQ: SNWV), fournisseur de solutions non invasives pour le soin des plaies, a été sélectionné pour être inclus dans le Russell 2000® Index dans le cadre de la reconstitution des indices Russell 2025, effective à partir du 30 juin. L'entreprise sera également incluse dans les indices plus larges Russell 3000® Index et Russell Microcap® Index.
Les indices Russell, qui regroupent les 4 000 plus grandes actions américaines par capitalisation boursière, sont largement utilisés par les gestionnaires d'investissements et les investisseurs institutionnels, avec environ 10,6 billions de dollars d'actifs référencés à ces indices en juin 2024. L'appartenance à ces indices est maintenue pour une durée d'un an.
Sanuwave Health est spécialisée dans les produits de médecine régénérative pour la cicatrisation des plaies, l'orthopédie/colonne vertébrale, l'esthétique/cosmétique et les affections cardiaques/endovasculaires grâce à leurs technologies brevetées de transfert d'énergie.
Sanuwave Health (NASDAQ: SNWV), ein Anbieter von nicht-invasiven Wundversorgungslösungen, wurde für die Aufnahme in den Russell 2000® Index im Rahmen der Neuzusammensetzung der Russell-Indizes 2025 ausgewählt, wirksam ab dem 30. Juni. Das Unternehmen wird zudem im breiteren Russell 3000® Index und im Russell Microcap® Index vertreten sein.
Die Russell-Indizes erfassen die 4.000 größten US-Aktien nach Marktkapitalisierung und werden von Investmentmanagern und institutionellen Anlegern weit verbreitet genutzt. Zum Juni 2024 beläuft sich das verwaltete Vermögen, das an diese Indizes gebunden ist, auf etwa 10,6 Billionen US-Dollar. Die Mitgliedschaft in diesen Indizes gilt für ein Jahr.
Sanuwave Health spezialisiert sich auf regenerative Medizinprodukte für die Wundheilung, Orthopädie/Wirbelsäule, Ästhetik/Kosmetik sowie kardiologische/endovaskuläre Erkrankungen durch ihre patentierten Energieübertragungstechnologien.
- Inclusion in Russell 2000® Index increases visibility to institutional investors
- Access to broader investor base through inclusion in multiple Russell indexes
- Potential for increased trading volume and liquidity due to index fund investments
- Association with indexes tracking $10.6 trillion in benchmarked assets
- None.
Insights
Sanuwave's inclusion in Russell 2000 Index increases visibility to institutional investors, potentially improving trading liquidity and passive fund inflows.
Sanuwave Health's inclusion in the Russell 2000® Index represents a significant milestone for the company's market visibility. The Russell indexes are not merely symbolic designations - they're powerful investment vehicles that directly influence capital flows. With approximately
The mechanics of this inclusion are particularly favorable. Sanuwave will join not only the Russell 2000® (small-cap companies) but also the broader Russell 3000® Index and the Russell Microcap® Index. This triple inclusion creates multiple channels for passive investment inflows, as index funds tracking these benchmarks will need to purchase Sanuwave shares to maintain proper tracking.
The timing of the reconstitution (effective June 30) gives the market a month to anticipate these mandatory purchases, potentially creating pre-inclusion price action. More importantly, the long-term benefits extend beyond temporary price movements. The increased liquidity typically reduces bid-ask spreads, making the stock more attractive to institutional investors who require sufficient trading volume. The increased analyst coverage that often follows Russell inclusion can further enhance market awareness of Sanuwave's wound care portfolio and regenerative medicine technologies.
The significance of this development should be viewed in context of Sanuwave's medical technology focus - an area where institutional backing can provide both capital resources and validation in a highly competitive healthcare landscape.
EDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, non-invasive wound care solutions, today announced, as part of the 2025 Russell indexes reconstitution, the Company’s inclusion in the Russell 2000® Index. This will be effective after the U.S. market opens on June 30. In addition to the Russell 2000® Index, the Company is also expected to be included in the broader Russell 3000® Index and in the Russell Microcap® Index.
The annual reconstitution of the Russell U.S. indexes captures the 4,000 largest U.S. stocks as of April 30, ranked by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, results in automatic inclusion in either the Russell 1000® Index or the Russell 2000® Index, as well as the appropriate growth and value style indexes. FTSE Russell determines index membership primarily by objective, market-capitalization rankings and style attributes.
The Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. As of June 2024, approximately
For more information about the Russell indexes and the annual reconstitution process, please visit the “Russell Reconstitution” section on the FTSE Russell website.
About Sanuwave
Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body's normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations, plans for future business development activities and expectations regarding the impact of changes in tariff rates. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company’s ability to manage its capital resources, competition and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact: investors@sanuwave.com
FAQ
When will Sanuwave Health (SNWV) be added to the Russell 2000 Index?
Which Russell indexes will SNWV be included in for 2025?
How long will Sanuwave Health remain in the Russell indexes?
What is Sanuwave Health's main business focus?
How much in assets are benchmarked to the Russell U.S. indexes?
